Truvada for HIV pre-exposure prophylaxis utilization in the United States (2013-2015)

被引：0
|
作者：
Mera, R. [1 ]
McCallister, S. [2 ]
Palmer, B. [3 ]
Mayer, G. [3 ]
Magnuson, D. [4 ]
Rawlings, K. [5 ]
机构：
[1] Gilead Sci, Epidemiol, Foster City, CA USA
[2] Clin Res, Gilead Sci, Foster City, CA USA
[3] Med Sci, Gilead Sci, Foster City, CA USA
[4] Drug Safety Publ Hlth, Gilead Sci, Foster City, CA USA
[5] Med Affairs, Gilead Sci, Foster City, CA USA
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2016年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
TUAX0105LB
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Two years of Truvada for pre-exposure prophylaxis utilization in the US
    Flash, Charlene
    Landovitz, Raphael
    Giler, Robertino Mera
    Ng, Leslie
    Magnuson, David
    Wooley, Staci Bush
    Rawlings, Keith
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 148 - 148
  • [2] Adolescent use of Truvada (FTC/TDF) for HIV pre-exposure prophylaxis (PrEP) in the United States (2012 to 2017)
    Magnuson, D.
    Hawkins, T.
    Mera, R.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21 : 18 - 18
  • [3] Initiation of HIV pre-exposure prophylaxis among youth in the United States, 2015-2018
    Barocas, Joshua A.
    Gai, Mam Jarra
    Nurani, Alykhan
    Bagley, Sarah M.
    Hadland, Scott E.
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2023, 35 (03): : 431 - 436
  • [4] Adherence and persistence of HIV pre-exposure prophylaxis use in the United States
    McCormick, Carter D.
    Sullivan, Patrick S.
    Qato, Dima M.
    Crawford, Stephanie Y.
    Schumock, Glen T.
    Lee, Todd A.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [5] Adherence to HIV Pre-Exposure Prophylaxis Testing Guidelines in the United States
    McCormick, Carter D.
    Sullivan, Patrick S.
    Qato, Dima M.
    Crawford, Stephanie Y.
    Schumock, Glen T.
    Lee, Todd A.
    [J]. AIDS PATIENT CARE AND STDS, 2023, 37 (07) : 337 - 350
  • [6] Real-world utilization of HIV pre-exposure prophylaxis (PREP) by cisgender and transgender individuals in the united states
    Thorburn, J.
    Paone, J.
    Kong, A.
    Bush, C.
    Patel, D.
    Carter, C.
    Das, M.
    Tao, L.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 175 - 175
  • [7] Prescribing of Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis by HIV Medical Providers in the United States, 2013-2014
    Weiser, John
    Garg, Shikha
    Beer, Linda
    Skarbinski, Jacek
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (01):
  • [8] HIV pre-exposure prophylaxis
    Sharma, Malika
    Tan, Darrell H. S.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2014, 186 (15) : E588 - E588
  • [9] HIV: Pre-exposure Prophylaxis
    Singh, Ajai Kumar
    Singh, Ashish
    Singh, Deepti
    Singh, Manish
    Singh, Pratibha
    Sharma, Abhishek
    [J]. INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2012, 3 (12) : 900 - 901
  • [10] HIV pre-exposure prophylaxis
    Fougere, Edouard
    [J]. ACTUALITES PHARMACEUTIQUES, 2024, 63 (638): : 14 - 16
12345